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Abstract
Stigma and stereotyping of marginalized groups often is insidious and shows up in unlikely places,
for instance in how clinical trials consider dropouts in treatment research. A surprising number of
studies presume that people who do not complete the study protocol relapse and code their data
as if they had been observed. There is no good statistical rationale for this treatment of missing
data and numerous and more defensible alternative methods are available. We need to be mindful
about our attitudes and preconceptions about the people we are intending to help. There is no
good reason to continue to support science built on this scientifically indefensible stereotyping,
however unintentional.
Background
Stigma and stereotyping of marginalized groups is alive
and well in the 21st century. Oftentimes, it is insidious. As
researchers, we sometimes like to think that negative atti-
tudes and bias are the afflictions of the less enlightened.
Like addiction though, these afflictions sometimes show
up in the least likely places.
Clinical trials and missing data
A fair number of clients drop out of treatment and clinical
trial studies. We typically do not know why subjects drop
out; whether or not they are using again and if they are, at
what level; and can make no direct assessments about out-
comes. Their data are missing. How clinical trials in addic-
tion research treat missing data depends on presumptions
about why the data are missing. Too often, we pass over
the assumptions because they are imbedded in the analy-
sis. Even when the presumptions are explicit, it is some-
times too easy to skim over the Methods Sections of
papers and not question the underlying assumptions of
the statistical analyses.
A close examination of the assumptions in a surprisingly
large number of published studies finds what can only be
described as stigma and stereotyping of individuals
because they are no longer participating in studies. There
are several options for how the dropouts and their data are
handled. The decision depends on the intent of the study
and presumptions about why the data are missing.
To find out how research reports in substance abuse/
dependence clinical trials generally dealt with their miss-
ing data, I did an informal review of recent clinical trials.
I selected 4 prominent journals (i.e. Alcoholism: Clinical
and Experimental Research, Alcohol and Alcoholism, Journal of
Studies on Alcohol and Drugs, Journal of Substance Abuse
Treatment) dealing with substance misuse. For each jour-
nal, I went back from the most recent issues until I found
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10 reports of clinical trials or went back 6 issues, which-
ever occurred first. This resulted in 34 articles on clinical
trials. I reviewed the reports' method of handling the
missing data. Of the 34 reports, 28 provided enough
information to tell what they did and 6 did not. A few
papers analyzed their data more than one way.
Missing data causes a problem for some analysis methods
that require complete data. One solution is to fill in or
impute the missing data and just go ahead with the full
sample pretending nothing was missing. The full sample
is called the "intent-to-treat sample" and this method of
filling in the missing data is called a "static imputation."
Static imputation introduces very restrictive assumptions
about the missing data, as well as several potential sources
of bias in the results. However unintentional, the num-
bers inserted in the data to fill the missing information are
based on the researchers' assumptions about the research
participant as if he or she would have been assessed. More
bluntly, the imputed data are the researchers' guesses.
Nearly a third (n = 11; 32.4%) of the recent 34 clinical
trial reports I read used static imputation, filling in the
missing data with a "best guess." All but two assumed that
the client had relapsed or returned to baseline levels of
use. The remaining two used the last observation to fill in
the missing data on subsequent assessments.
There is little statistical reason for using any static imputa-
tion method [1-3] so what might drive the decision to
assume that all dropouts are relapsing? There may be a
few good reasons. One might be to make the current anal-
ysis replicate an old study done before more modern
methods of dealing with missing data were available.
Another reason, and sometimes given, is that filling in the
missing outcomes as "relapsed" makes the analysis more
"conservative". That reasoning assumes that there are
more dropouts in the treatment arm than in the compari-
son arm. However, a researcher would not know that
before hand and the method for treating missing data
should be specified a priori [4]. Furthermore, this method
is not more conservative from a statistical perspective
since it does not add in any error associated with not
knowing what the real outcomes were. The sample size of
real observations is also artificially inflated.
Since the mid 1980s, there have been considerable
advancements in the statistical analysis of data with miss-
ing values. For example, the technique of multiple impu-
tation introduced in the mid 1980s [5,6]. This method
explicitly adjusts the error terms for the uncertainty sur-
rounding the missing data. Other likelihood methods are
available [7]. Still other options exist, for example simply
using a statistical method that does not require complete
data on all subjects – random regression, mixed models,
or generalized estimating equations, survival analysis.
These methods have been available since at least the late
1980s. Only 7 of the 34 articles (20.6%) indicated one of
these more appropriate statistical treatments.
Conclusion
Many published papers explicitly assume with no sup-
porting information that clients initiating treatment but
not completing the study protocol, relapse. Aside from the
bias that this might introduce into the science, this prac-
tice supports, without basis, a negative message. We need
to be mindful about our attitudes and preconceptions
about the people we are intending to help. There is no
good reason to continue to support science built on this
unintentional stereotyping.
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